Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2019

01-09-2019 | Suicide | Review

Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice

Authors: Paulo Pimentel de Assumpção, Taíssa Maíra Thomaz Araújo, Paula Baraúna de Assumpção, Williams Fernandes Barra, André Salim Khayat, Carolina Baraúna Assumpção, Geraldo Ishak, Diana Noronha Nunes, Emmanuel Dias-Neto, Luiz Gonzaga Vaz Coelho

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2019

Login to get access

Abstract

Despite being one of the most studied cancer-related infections, the relationship between Helicobacter pylori infection and gastric adenocarcinoma (GC) remains, in some points, obscure. Based on a critical analysis of the available literature regarding stomach microbiota, we aimed to shed light to a possible new interpretation of the current understanding about the Helicobacter pylori-related GC carcinogenesis. We analyzed data from the literature on Helicobacter pylori and other potential carcinogenic pathogens, in both benignant conditions and gastric adenocarcinoma. Helicobacter pylori is the dominant microorganism in benignant conditions as non-complicated gastritis. In atrophic gastritis, metaplasia and, mainly, in gastric adenocarcinoma, a strong reduction in Helicobacter pylori abundance, and increased occurrence of other microorganisms is strongly demonstrated by metagenomic experiments. While causing peptic disease and keeping the stomach’s high acidity, Helicobacter pylori infection avoids gastric infection by carcinogenic intestinal microbiota. Nevertheless, Helicobacter pylori persistence may also provoke an atrophic gastritis, a condition that causes its own decline, due to a microenvironment modification, including reduced acidity, resulting in Helicobacter pylori substitution by a cancer-prone microbiota. This new interpretation might result in a dramatic modification on clinical management of Helicobacter pylori-related gastric disease.
Literature
1.
7.
9.
go back to reference Annibale B, Aprile MR, D’ambra G, Caruana P, Bordi C, Delle Fave G (2000) Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 14:625–634CrossRefPubMed Annibale B, Aprile MR, D’ambra G, Caruana P, Bordi C, Delle Fave G (2000) Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 14:625–634CrossRefPubMed
10.
go back to reference Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ (2017) Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 11:670–673CrossRef Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ (2017) Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 11:670–673CrossRef
22.
go back to reference Yu G, Torres J, Hu N, Medrano-Guzman R, Herrera-Goepfert R, Humphrys MS, Wang L, Wang C, Ding T, Ravel J, Taylor PR, Abnet CC, Goldstein AM (2017) Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2017.00302 Yu G, Torres J, Hu N, Medrano-Guzman R, Herrera-Goepfert R, Humphrys MS, Wang L, Wang C, Ding T, Ravel J, Taylor PR, Abnet CC, Goldstein AM (2017) Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol. https://​doi.​org/​10.​3389/​fcimb.​2017.​00302
23.
go back to reference Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J (2014) Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep. https://doi.org/10.1038/srep04202 Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, Mantilla A, Torres J (2014) Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep. https://​doi.​org/​10.​1038/​srep04202
27.
go back to reference Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, Kosunen TU (2000) Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 35:138–141CrossRefPubMed Kokkola A, Rautelin H, Puolakkainen P, Sipponen P, Färkkilä M, Haapiainen R, Kosunen TU (2000) Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol 35:138–141CrossRefPubMed
28.
go back to reference Matsukura N, Onda M, Yamashita K (1995) Helicobacter pylori in peptic ulcer and gastric cancer. Gan To Kagaku Ryoho 22:169–178PubMed Matsukura N, Onda M, Yamashita K (1995) Helicobacter pylori in peptic ulcer and gastric cancer. Gan To Kagaku Ryoho 22:169–178PubMed
38.
go back to reference Meng W, Bai B, Sheng L, Li Y, Yue P, Li X, Qiao L (2015) Role of Helicobacter pylori in gastric cancer: advances and controversies. Discov Med 20:285–293PubMed Meng W, Bai B, Sheng L, Li Y, Yue P, Li X, Qiao L (2015) Role of Helicobacter pylori in gastric cancer: advances and controversies. Discov Med 20:285–293PubMed
39.
go back to reference Assumpção MB, Martins LC, Melo Barbosa HP, Barile KA, de Almeida SS, Assumpção PP, Corvelo TC (2010) Helicobacter pylori in dental plaque and stomach of patients from Northern Brazil. World J Gastroenterol 16:3033–3039CrossRefPubMedPubMedCentral Assumpção MB, Martins LC, Melo Barbosa HP, Barile KA, de Almeida SS, Assumpção PP, Corvelo TC (2010) Helicobacter pylori in dental plaque and stomach of patients from Northern Brazil. World J Gastroenterol 16:3033–3039CrossRefPubMedPubMedCentral
41.
46.
47.
48.
go back to reference IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Schistosomes, liver flukes and Helicobacter pylori. Lyon, 1994. IARC Monogr Eval Carcinog Risks Hum 61:1–241 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1994) Schistosomes, liver flukes and Helicobacter pylori. Lyon, 1994. IARC Monogr Eval Carcinog Risks Hum 61:1–241
51.
go back to reference Shao J, Sartor RB, Dial E, Lichtenberger LM, Schepp W, Alpers DH (2000) Expression of intrinsic factor in rat and murine gastric mucosal cell lineages is modified by inflammation. Am J Pathol 157:1197–1205CrossRefPubMedPubMedCentral Shao J, Sartor RB, Dial E, Lichtenberger LM, Schepp W, Alpers DH (2000) Expression of intrinsic factor in rat and murine gastric mucosal cell lineages is modified by inflammation. Am J Pathol 157:1197–1205CrossRefPubMedPubMedCentral
Metadata
Title
Suicide journey of H. pylori through gastric carcinogenesis: the role of non-H. pylori microbiome and potential consequences for clinical practice
Authors
Paulo Pimentel de Assumpção
Taíssa Maíra Thomaz Araújo
Paula Baraúna de Assumpção
Williams Fernandes Barra
André Salim Khayat
Carolina Baraúna Assumpção
Geraldo Ishak
Diana Noronha Nunes
Emmanuel Dias-Neto
Luiz Gonzaga Vaz Coelho
Publication date
01-09-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03564-5

Other articles of this Issue 9/2019

European Journal of Clinical Microbiology & Infectious Diseases 9/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.